Shaping better health
REMEDY : BNSSG referral pathways & Joint Formulary

Home > Formulary : Adult > Chapters > 6. Endocrine System >

BNSSG Adult Joint Formulary

6.5 Dopamine responsive conditions

Checked: not set yet by Next Review: not set yet

First line drugs Second line drugs Specialist drugs Secondary care drugs


Dopamine-receptor agonists

Cabergoline (TLS Amber 3 month) (SCP click here)


Bromocriptine (TLS Amber 3 month) (SCP click here)

Specific indication:

Quinagolide (Awaiting SCP)

  • The treatment of hyperprolactinaemia & prolactinomas where other treatments have failed, are contraindicated or the patient has had adverse effects
  • Quinagolide offers a non-ergot derived treatment option


Contact Us

Got a question or comment about the Joint Formulary? 

Please use the email address below to contact us and we will endeavour to respond within 2 working days.